If you have primary mediastinal B-cell lymphoma (PMBL), you’ve likely heard about CAR T gene therapy. There’s good reason for that. Loretta Nastoupil, MD, will tell you, “It’s just the most exciting ...
Please provide your email address to receive an email when new articles are posted on . The University of Texas MD Anderson Cancer Center announced a new commercial development partnership with San ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Flinn: Hello, ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Flinn: Hello, ...
Loretta J. Nastoupil, MD: Hello, and welcome to CURE Expert Connections®. I am Loretta Nastoupil from the University of Texas MD Anderson Cancer Center, and I’m joined today by one of my patients, ...
Highlights in non-Hodgkin lymphoma from the Society of Hematologic Oncology (SOHO) 2023 annual meeting, including studies on chimeric antigen receptor (CAR) T-cell therapy, bispecific antibodies, and ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Amelia Langston, ...
Even though it’s one of the latest and greatest cancer treatments, CAR T therapy still has its side effects. They’re often mild, but they can be serious and affect your heart, kidneys, and brain. That ...
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback